Cite
HARVARD Citation
Mullins, E. et al. (2017). Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A. Haemophilia. 23 (2), pp. 238-246. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mullins, E. et al. (2017). Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A. Haemophilia. 23 (2), pp. 238-246. [Online].